US Stock MarketDetailed Quotes

ZBIO Zenas BioPharma

Watchlist

10.010
+0.250+2.56%

Close Dec 20 16:00 ET

10.030
+0.020+0.20%

Post 17:17 ET

418.33MMarket Cap-3.24P/E (TTM)

Zenas BioPharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

Total revenue

50M

Operating revenue

--0

--50M

--0

--50M

--0

Cost of revenue

Gross profit

Operating expense

185.09%40.98M

110.01%39.7M

44.49%27.58M

2.59%77.15M

30.49%24.78M

14.38M

18.91M

19.09M

75.2M

18.99M

Selling and administrative expenses

48.37%7.45M

47.74%5.9M

31.93%4.93M

26.68%17.11M

35.27%4.36M

--5.02M

--3.99M

--3.74M

--13.51M

--3.22M

-General and administrative expense

48.37%7.45M

47.74%5.9M

31.93%4.93M

26.68%17.11M

35.27%4.36M

--5.02M

--3.99M

--3.74M

--13.51M

--3.22M

Research and development costs

258.53%33.53M

126.66%33.81M

47.55%22.65M

-2.68%60.03M

29.51%20.42M

--9.35M

--14.92M

--15.35M

--61.69M

--15.77M

Operating profit

-215.05%-40.98M

-110.01%-39.7M

-44.49%-27.58M

63.90%-27.15M

-30.49%-24.78M

35.62M

-18.91M

-19.09M

-75.2M

-18.99M

Net non-operating interest income expense

Other net income (expense)

14,962.50%2.38M

117.01%1.73M

-1,918.18%-222K

78.05%-9.68M

9,960.00%493K

-16K

-10.14M

-11K

-44.08M

-5K

Gain on sale of security

----

---13.27M

--0

Special income (charges)

--0

----

-900.00%-10M

--0

----

---1M

--0

-Less：Restructuring and merger&acquisition

--0

----

900.00%10M

--0

----

--1M

--0

Other non- operating income (expenses)

14,962.50%2.38M

1,314.79%1.73M

-1,918.18%-222K

101.09%324K

9,960.00%493K

---16K

---142K

---11K

---29.82M

---5K

Income before tax

-208.42%-38.61M

-30.74%-37.98M

-45.57%-27.8M

69.13%-36.82M

-27.86%-24.29M

35.61M

-29.05M

-19.1M

-119.28M

-18.99M

Income tax

301K

Net income

-208.42%-38.61M

-30.74%-37.98M

-45.57%-27.8M

68.88%-37.12M

-29.45%-24.59M

35.61M

-29.05M

-19.1M

-119.28M

-18.99M

Net income continuous Operations

-208.42%-38.61M

-30.74%-37.98M

-45.57%-27.8M

68.88%-37.12M

-29.45%-24.59M

--35.61M

---29.05M

---19.1M

---119.28M

---18.99M

Minority interest income

Net income attributable to the parent company

-208.42%-38.61M

-30.74%-37.98M

-45.57%-27.8M

68.88%-37.12M

-29.45%-24.59M

35.61M

-29.05M

-19.1M

-119.28M

-18.99M

Preferred stock dividends

3.77M

Other preferred stock dividends

28.12M

Net income attributable to common stockholders

-1,136.96%-38.61M

-30.74%-37.98M

-45.57%-27.8M

68.88%-37.12M

-29.45%-24.59M

3.72M

-29.05M

-19.1M

-119.28M

-18.99M

Basic earnings per share

-2,448.32%-5.02

42.78%-0.9544

36.29%-0.6986

68.90%-2.88

-29.45%-1.4118

0.2138

-1.6678

-1.0965

-9.2613

-1.0906

Diluted earnings per share

-2,448.32%-5.02

42.78%-0.9544

36.29%-0.6986

68.90%-2.88

-29.45%-1.4118

0.2138

-1.6678

-1.0965

-9.2613

-1.0906

Dividend per share

Currency Unit

USD

	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022
Total revenue	0	0	0	50M	0	50M	0	0	0	0
Operating revenue	--0	--0	--0	--50M	--0	--50M	--0	--0	--0	--0
Cost of revenue
Gross profit
Operating expense	185.09%40.98M	110.01%39.7M	44.49%27.58M	2.59%77.15M	30.49%24.78M	14.38M	18.91M	19.09M	75.2M	18.99M
Selling and administrative expenses	48.37%7.45M	47.74%5.9M	31.93%4.93M	26.68%17.11M	35.27%4.36M	--5.02M	--3.99M	--3.74M	--13.51M	--3.22M
-General and administrative expense	48.37%7.45M	47.74%5.9M	31.93%4.93M	26.68%17.11M	35.27%4.36M	--5.02M	--3.99M	--3.74M	--13.51M	--3.22M
Research and development costs	258.53%33.53M	126.66%33.81M	47.55%22.65M	-2.68%60.03M	29.51%20.42M	--9.35M	--14.92M	--15.35M	--61.69M	--15.77M
Operating profit	-215.05%-40.98M	-110.01%-39.7M	-44.49%-27.58M	63.90%-27.15M	-30.49%-24.78M	35.62M	-18.91M	-19.09M	-75.2M	-18.99M
Net non-operating interest income expense
Other net income (expense)	14,962.50%2.38M	117.01%1.73M	-1,918.18%-222K	78.05%-9.68M	9,960.00%493K	-16K	-10.14M	-11K	-44.08M	-5K
Gain on sale of security	----	----	----	----	----	----	----	----	---13.27M	--0
Special income (charges)	--0	----	----	-900.00%-10M	--0	--0	----	----	---1M	--0
-Less：Restructuring and merger&acquisition	--0	----	----	900.00%10M	--0	--0	----	----	--1M	--0
Other non- operating income (expenses)	14,962.50%2.38M	1,314.79%1.73M	-1,918.18%-222K	101.09%324K	9,960.00%493K	---16K	---142K	---11K	---29.82M	---5K
Income before tax	-208.42%-38.61M	-30.74%-37.98M	-45.57%-27.8M	69.13%-36.82M	-27.86%-24.29M	35.61M	-29.05M	-19.1M	-119.28M	-18.99M
Income tax				301K					0
Net income	-208.42%-38.61M	-30.74%-37.98M	-45.57%-27.8M	68.88%-37.12M	-29.45%-24.59M	35.61M	-29.05M	-19.1M	-119.28M	-18.99M
Net income continuous Operations	-208.42%-38.61M	-30.74%-37.98M	-45.57%-27.8M	68.88%-37.12M	-29.45%-24.59M	--35.61M	---29.05M	---19.1M	---119.28M	---18.99M
Minority interest income
Net income attributable to the parent company	-208.42%-38.61M	-30.74%-37.98M	-45.57%-27.8M	68.88%-37.12M	-29.45%-24.59M	35.61M	-29.05M	-19.1M	-119.28M	-18.99M
Preferred stock dividends						3.77M
Other preferred stock dividends	0					28.12M
Net income attributable to common stockholders	-1,136.96%-38.61M	-30.74%-37.98M	-45.57%-27.8M	68.88%-37.12M	-29.45%-24.59M	3.72M	-29.05M	-19.1M	-119.28M	-18.99M
Basic earnings per share	-2,448.32%-5.02	42.78%-0.9544	36.29%-0.6986	68.90%-2.88	-29.45%-1.4118	0.2138	-1.6678	-1.0965	-9.2613	-1.0906
Diluted earnings per share	-2,448.32%-5.02	42.78%-0.9544	36.29%-0.6986	68.90%-2.88	-29.45%-1.4118	0.2138	-1.6678	-1.0965	-9.2613	-1.0906
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD

Heat List

Overall

No Data

Investment Theme

Recent IPOs

Intraday+0.71%